Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study
Real-world evidence regarding the effectiveness of prulifloxacin in the treatment of acute exacerbations of chronic bronchitis (AECB) is limited. Therefore, this study aimed to assess the rates and time to symptom improvement and resolution in patients with moderate-to-severe AECB who were given pru...
Main Authors: | Konstantinos Gourgoulianis, Alessandro Ruggieri, Alessandra del Vecchio, Fabrizio Calisti, Alessandro Comandini, Giovanna Esposito, Giorgio Di Loreto, Nikolaos Tzanakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2021/6620585 |
Similar Items
-
Prulifloxacin in the treatment of acute exacerbations of COPD in cigarette smokers
by: Franco Pasqua, et al.
Published: (2008-08-01) -
Pharmacokinetics of Oral Prulifloxacin Capsules in Healthy Volunteers
by: Jing Zou, et al.
Published: (2011-03-01) -
Aiolos : a new cloud storage system
by: Hsu, Wen-Feng, et al.
Published: (2011) -
Greatest International ANtiinfective Trial (GIANT) with moxifloxacin in the treatment of acute exacerbation of  chronic bronchitis: subanalysis of Chinese data of a global, multicenter, noninterventional study
by: Yulin Feng, et al.
Published: (2010-03-01) -
Rapid europium-sensitized fluorescent determination of ulifloxacin, the active metabolite of prulifloxacin, in human serum and urine
by: Peng Dong, et al.
Published: (2011-02-01)